oncology

You have access
Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers
Thomas A. Hope, Matthias Benz, Fei Jiang, Daniel Thompson, Francesco Barbato, Roxana Juarez, Miguel Hernandez Pampaloni, Martin Allen-Auerbach, Pawan Gupta, Wolfgang P. Fendler and Jeremie Calais

Journal of Nuclear Medicine August 17, 2023, jnumed.123.265916; DOI: https://doi.org/10.2967/jnumed.123.265916
Open Access
Initial Evaluation of [¹⁸F]FAPI-74 PET for Various Histopathologically Confirmed Cancers and Benign Lesions
Tadashi Watabe, Sadahiro Naka, Mitsuaki Tatsumi, Takashi Kamiya, Toru Kimura, Yasushi Shintani, Kaori Abe, Tomohiro Miyake, Kenzo Shimazu, Shogo Kobayashi, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki, Hidenori Inohara, Hiroki Kato, Yuriko Mori, Jens Cardinale and Frederik L. Giesel

Journal of Nuclear Medicine August 1, 2023, 64 (8) 1225-1231; DOI: https://doi.org/10.2967/jnumed.123.265486
You have access
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
Nader Hirmas, Rainer Hamacher, Miriam Sraieb, Marc Ingenwerth, Lukas Kessler, Kim M. Pabst, Francesco Barbato, Katharina Lueckerath, Stefan Kasper, Michael Nader, Hans-Ulrich Schildhaus, Claudia Kesch, Bastian von Tresckow, Christine Hanoun, Hubertus Hautzel, Clemens Aigner, Martin Glas, Martin Stuschke, Sherko Kümmel, Philipp Harter, Celine Lugnier, Waldemar Uhl, Marco Niedergethmann, Boris Hadaschik, Viktor Grünwald, Jens T. Siveke, Ken Herrmann and Wolfgang P. Fendler

Journal of Nuclear Medicine May 1, 2023, 64 (5) 711-716; DOI: https://doi.org/10.2967/jnumed.122.264689
You have access
Targeted α-Therapy Using ²²⁵Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment
Thomas Ertveldt, Ahmet Krasniqi, Hannelore Ceuppens, Janik Puttemans, Yana Dekempeneer, Kevin De Jonghe, Wout de Mey, Quentin Lecocq, Yannick De Vlaeminck, Robin Maximilian Awad, Cleo Goyvaerts, Kim De Veirman, Alfred Morgenstern, Frank Bruchertseifer, Marleen Keyaerts, Nick Devoogdt, Matthias D’Huyvetter and Karine Breckpot

Journal of Nuclear Medicine May 1, 2023, 64 (5) 751-758; DOI: https://doi.org/10.2967/jnumed.122.264752
Open Access
²²⁵Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors
A. Paden King, Nicholas T. Gutsche, Natarajan Raju, Stanley Fayn, Kwamena E. Baidoo, Meghan M. Bell, Colleen S. Olkowski, Rolf E. Swenson, Frank I. Lin, Samira M. Sadowski, Stephen S. Adler, Nikki A. Thiele, Justin J. Wilson, Peter L. Choyke and Freddy E. Escorcia

Journal of Nuclear Medicine April 1, 2023, 64 (4) 549-554; DOI: https://doi.org/10.2967/jnumed.122.264707
You have access
2022 SNMMI Highlights Lecture: Oncology and Therapy, Part 2
Heiko Schöder

Journal of Nuclear Medicine January 1, 2023, 64 (1) 2-7; DOI: https://doi.org/10.2967/jnumed.122.265202
You have access
Nanoparticle Diagnostics and Theranostics in the Clinic
Roger M. Pallares, Felix M. Mottaghy, Volkmar Schulz, Fabian Kiessling and Twan Lammers

Journal of Nuclear Medicine December 1, 2022, 63 (12) 1802-1808; DOI: https://doi.org/10.2967/jnumed.122.263895
You have access
Safety and Efficacy of ¹⁶⁶Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary Study
Margot T.M. Reinders, Karel J. van Erpecum, Maarten L.J. Smits, Arthur J.A.T. Braat, Joep de Bruijne, Rutger Bruijnen, Dave Sprengers, Robert A. de Man, Erik Vegt, Jan N.M. IJzermans, Adriaan Moelker and Marnix G.E.H. Lam

Journal of Nuclear Medicine December 1, 2022, 63 (12) 1891-1898; DOI: https://doi.org/10.2967/jnumed.122.263823
Open Access
Use of ⁶⁴Cu-DOTA-Trastuzumab PET to Predict Response and Outcome of Patients Receiving Trastuzumab Emtansine for Metastatic Breast Cancer: A Pilot Study
Joanne E. Mortimer, James R. Bading, Paul H. Frankel, Mary I. Carroll, Yuan Yuan, Jinha M. Park, Lusine Tumyan, Nikita Gidwaney, Erasmus K. Poku, John E. Shively and David M. Colcher

Journal of Nuclear Medicine August 1, 2022, 63 (8) 1145-1148; DOI: https://doi.org/10.2967/jnumed.121.262940
You have access
Signaling Pathways That Drive ¹⁸F-FDG Accumulation in Cancer
Jessica R. Salas and Peter M. Clark

Journal of Nuclear Medicine May 1, 2022, 63 (5) 659-663; DOI: https://doi.org/10.2967/jnumed.121.262609

Main menu

User menu

Search

oncology

Pages